antitumor
Showing 1 - 25 of 3,889
HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor
Not yet recruiting
- HER2-expressing Advanced Solid Tumors
- SHR-A1811 combined with Pyrotinib.
- SHR-A1811 combined with other antitumor therapies
- (no location specified)
Aug 28, 2023
Tumor Patients With COVID19 Infection
Recruiting
- Tumor
- COVID-19
-
Shenzhen, Guangdong, ChinaSeventh Affiliated Hospital, Sun Yat-sen University
Aug 22, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B)
Active, not recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jan 18, 2023
Cancer Therapy-related Cardiovascular Toxicity Trial in Beijing (Bifidobacterium Bifidum Oral Capsule, Cisplatin, Carboplatin)
Not yet recruiting
- Cancer Therapy-related Cardiovascular Toxicity
- Bifidobacterium Bifidum Oral Capsule
- +4 more
-
Beijing, ChinaPeking University Third Hospital
Feb 15, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B KAC)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B KAC
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 6, 2022
Glioblastoma Trial in Morgantown (Daratumumab)
Recruiting
- Glioblastoma
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Dec 5, 2022
Solid Tumor, Adult Trial in Chisinau, Madrid, Pamplona (GEN1056)
Recruiting
- Solid Tumor, Adult
- GEN1056
-
Chisinau, Moldova, Republic of
- +2 more
Dec 9, 2022
Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- (no location specified)
Dec 15, 2022
Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Atezolizumab
- +2 more
-
Taoyuan City, TaiwanChang Gung Memorial Hospital at Linkou
Nov 17, 2023
Remaxol® in Drug-induced Liver Injuries During Antitumor Therapy
Recruiting
- Cancer
- Drug Induced Liver Injury
-
Krasnoyarsk, Russian Federation
- +4 more
Mar 16, 2023
Advanced Malignant Solid Tumors Trial in Changchun (Cisplatin micelle injection (HA132))
Not yet recruiting
- Advanced Malignant Solid Tumors
- Cisplatin micelle injection (HA132)
-
Changchun, Jilin, ChinaJilin Cancer Hospital
Jul 28, 2022
Solid Tumor Trial in Beijing (Hemay181)
Not yet recruiting
- Solid Tumor
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 27, 2023
Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)
Recruiting
- Solid Tumor
- B-Raf Mutation-Related Tumors
-
Boston, Massachusetts
- +4 more
Oct 25, 2022
Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Shanghai, China复旦大学附属中山医院
Mar 23, 2023
Advanced Cancer Trial in Australia (AK-105)
Active, not recruiting
- Advanced Cancer
- AK-105
-
Darlinghurst, New South Wales, Australia
- +4 more
Oct 20, 2022
Tumors Trial in Worldwide (Letetresgene autoleucel)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel
-
Pittsburgh, Pennsylvania
- +5 more
Aug 7, 2023
Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)
Not yet recruiting
- Acral Melanoma
- Mucosal Melanoma
- Pembrolizumab, Vactosertib
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jun 23, 2022
Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)
Not yet recruiting
- Advanced Solid Tumors
-
Hackensack, New Jersey
- +10 more
Jun 6, 2023
